Press Releases Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:56 2024-04-26 am EDT			5-day change	1st Jan Change
886.6 ^DKK	+2.28%		+2.36%	+27.00%

Apr. 25	NOVO NORDISK : JP Morgan gives a Buy rating	ZD
Apr. 25	Scholz promises support for pharma sector in Germany as Merck invests	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period \| Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals	Apr. 26	AQ
Novo Nordisk A/S : Reduction of the share capital	Apr. 24	PU
Novo Nordisk A/S - Articles of Association, April 2024	Apr. 24	GL
Novo Nordisk A/S – Reduction of the share capital	Apr. 24	GL
Novo Nordisk A/S - share repurchase programme	Apr. 22	GL
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut	Apr. 21	AQ
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	Apr. 15	GL
Novo Nordisk A/S - share repurchase programme	Apr. 15	GL
Novo Nordisk A/S - share repurchase programme	Apr. 08	GL
Novo Nordisk A/S - share repurchase programme	Apr. 02	GL
Revolutionizing Targeted Cancer Treatment and Radiotherapy Manufacturing: Actinium Pharmaceuticals (NYSE: ATNM) Trailblazing Journey	Mar. 28	AQ
Fitch Affirms DBGS 2018-BIOD Mortgage Trust	Mar. 28	AQ
Novo Nordisk A/S - share repurchase programme	Mar. 25	GL
Novo Nordisk to buy Cardior Pharmaceuticals	Mar. 25	AQ
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease	Mar. 25	GL
Novo Nordisk A/S - Articles of Association 2024	Mar. 25	GL
Novo Nordisk A/S - Articles of Association 2024	Mar. 25	AQ
Medicare now will cover weight-loss drug Wegovy for heart patients	Mar. 21	AQ
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities	Mar. 21	GL
Resolutions from the Annual General Meeting of Novo Nordisk A/S	Mar. 21	AQ